Advisory Board and Editors Pharmacology
Thomas Hartung
Professor of Toxicology (Chair for Evidence-based Toxicology), Pharmacology, Molecular Microbiology and Immunology at Johns Hopkins Bloomberg School of Public Health, Baltimore, and University of Konstanz, Germany; Director of their Centers for Alternatives to Animal Testing (CAAT). Former Head of the European Center for the Validation of Alternative Methods (ECVAM), Ispra, Italy.
Hidekazu Hiroaki
Dr. Hidekazu Hiroaki is Professor within the Graduate School of Pharmaceutical Sciences, Nagoya University, Japan. He received his PhD in Pharmaceutical Sciences (PhD thesis "Spectroscopic study for interaction between DNA oligonucleotide and bleomycin”) from the Graduate School of Osaka University, Japan in 1992.
Dr Hiroaki's research focuses on the structural biology of proteins by using solution NMR techniques, including protein-protein and protein-drug interaction. He is also focusing on NMR-assisted in silico drug discovery as well as protein structure determination. He is also an expert of intrinsically disordered proteins and some disease related amyloid genic proteins.
Professional experience:
2012-present: Professor, Graduate School of Pharmaceutical Sciences, Nagoya University (Nagoya, Aichi, Japan)
2011-2012: Professor, Research Center for Structural Biology, Department of Science, Nagoya University (Nagoya, Aichi, Japan)
2007-2011: Professor, Division of Structural Biology, Graduate School of Medicine, Kobe University, (Kobe, Hyogo, Japan)
2001-2007: Associate Professor, International Graduate School of Art and Science, Yokohama City University, (Kanagawa, Japan)
1995-2001: Research Scientist, Division of Structural Biology, Biomolecular Engineering Research Institute (BERI) (Suita, Osaka, Japan)
1994-1995: Visiting Scientist, Research Centre, F Hoffman La Roche (Basel, Switzerland)
1992-1994: Research Scientist, Department of Molecular Genetics, Nippon Roche Research Center (Kanagawa, Japan)
Noriko F Hiroi
Noriko Hiroi is Assistant Professor of the Department of Biosciences and Informatics, Keio University. She started to develop her career in Molecular Biology and Biochemistry, and currently works in Systems Biology and Quantitative Biology area. Her research interest includes in vivo oriented modelling, molecular mechanisms of higher-functions of central nerve systems, microfluidics technology and optical technologies and informatics for bioimaging.
Victor J. Hruby
Regents Professor of Chemistry and Biochemistry at the University of Arizona. Professor of Neuroscience recently inducted into the ACS Hall of Fame and 2011 ACS Goodman Award for Scientific Excellence and Mentorship.
Zunnan Huang
Professor in Chemistry; Director, Key Laboratory of Big Data Mining and Precision Drug Design; Director, Key Laboratory of Computer-Aided Drug Design of Dongguan City; Vice Dean, Graduate School of Guangdong Medical University; PhD in Computational Chemistry and Physical Chemistry obtained from the University of Oklahoma; Guest Editor, Current Pharmaceutical Design, Current Medicinal Chemistry, Frontiers in Chemistry, Molecules; Reviewer for more than 50 SCI journals including Journal of the American Chemical Society, Science Advances, Nature Communications and Briefings in Bioinformatics. Authors of more than 117 SCI papers with an accumulated IF of 600.
Marcello Iriti
Dr. Marcello Iriti is an Associate Professor of Plant Biology and Pathology within the Department of Agricultural and Environmental Sciences at the University of Milan.
He has been studying nutraceuticals, functional foods, phytotherapeutics and essential oils relevant for human and animal health, focusing on their preclinical (in vitro/in vivo) and in human pharmacological activities. He has also been investigating the health-promoting effects of traditional Mediterranean diet as well as the ethnopharmacology of herbal remedies of traditional healing systems.
Dr. Iriti is a Member of the World Academy of Sciences, Asian Council of Science Editors and Society of African Journal Editors. Founding Member of the Italian Society of Environmental Medicine. Member of the Working Group ‘Pharmacognosy, Phytotherapy and Nutraceuticals’ of the Italian Pharmacological Society.
Md Asiful Islam
Dr Asiful is currently working as a research fellow at the WHO Collaborating Centre for Global Women’s Health, Institute of Metabolism and Systems Research, College of Medical and Dental Sciences, University of Birmingham, UK.
Dr Md Asiful Islam completed his PhD (Fast Track, Passed with Grade 1, Pass without correction) in Genetics & Autoimmunity from Human Genome Centre, Universiti Sains Malaysia (November 2018) under Professor Dr Siew Hua Gan following completing BSc in Biochemistry & Molecular Biology (Jahangirnagar University, Dhaka, Bangladesh). He achieved Malaysia International Scholarship and USM Vice-Chancellor Award during his PhD and working as a Senior Lecturer at the Department of Haematology, School of Medical Sciences, Universiti Sains Malaysia from 2019 till 2022.
Besides PeerJ, he has been working as an Academic Editor for Nature Scientific Data, PLOS ONE, BMC Rheumatology, Autoimmunity Highlights, Endocrine, Metabolic & Immune Disorders - Drug Targets, Current Immunology Reviews and Current Rheumatology Reviews.
Dr Asiful's research interest covers different research areas of Medical Sciences including Haematology, Immunology, Pharmacology, Molecular Genetics and Neurosciences. He is currently focused on developing and executing systematic reviews and meta-analyses decoding various research questions of Medical Sciences.
Ji Hoon Jeong
Associated professor in college of medicine, Chung-Ang university.
Alex Kentsis
Assistant Professor of Pediatrics at the Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College of Cornell University.
He leads research in the functional proteomics and genomic plasticity of refractory childhood cancers.
Haseeb A. Khan
Distinguished Professor of Biochemistry at College of Science, King Saud University, Riyadh, Saudi Arabia. Group Leader of Analytical and Molecular Bioscience Research Group and a Chair Professor at Research Chair for Biomedical Applications of Nanomaterials, King Saud University. PhD from Aligarh Muslim University, Aligarh, India and received scientific trainings in USA, UK, Denmark and Finland. Fellow of the Royal College of Pathologists (FRCPath) and the Royal Society of Chemistry (FRSC), UK. Authored more than 300 publications including 2 books and 20 book chapters. Recipient of Microsoft eScience Award. Listed in Top-2% World Ranking of Scientists. Research interests are clinical biochemistry, analytical chemistry, environmental chemistry, nanobiotechnology, molecular conservation, bioinformatics, pharmacology, and toxicology.
Mei-Chuan Ko
Professor in the Department of Psychiatry, University of Pittsburgh School of Medicine. My research interests involve behavioral neuropharmacology of pain and addiction, including 1) biological basis and pharmacotherapy for drug abuse and dependence and 2) neuropharmacological basis of therapeutics of analgesics and antipruritics.
Hang Fai Kwok
Prof Kwok’s research interests mainly focus on the development of novel monoclonal antibodies and venom-based peptides as prototype drugs for anticancer and anti-inflammatory therapies. In addition, Prof. Kwok’s research group is also expanding scientific knowledge and research in the areas of existing and novel cancer biomarkers such as 1) matricellular protein — OPN, 2) metalloproteinase — ADAM17 & ADAMTS5, 3) DNA replication licensing factor — MCM proteins, 4) small GTP binding protein — RAN, as well as immunotherapy markers (e.g. PD-1/PD-L1) in order to identify and validate their prognostic and therapeutic values according to the roles in hallmarks of cancer.